课题基金 / 基金详情

Gene regulation and cell differentiation of FGF8

Gene regulation and cell differentiation of FGF8
FGF8的基因调控和细胞分化
批准号:
09670235
负责人:
TANAKA Akira
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

TANAKA Akira的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. Characterization of fgf8 gene regulation The promoter of the fgf8 gene was found within 300 b.p. of the 5'-flanking region. Its promoter activity was not affected in the presence of 10 nM testosterone. In addition, various reporter constructs, including the introns and the 3'-region, failed to show any androgen-responsive region in the fgf8 gene.2. Isolation of a growth factor secreted from androgen-independent Shionogi carcinoma cells: The secreted growth factor was finally identified as activin from the facts that the stimulated growth is completely blocked by activin-binding protein, follistatin, and that immunoreactive substances with anti-activin βA and βB antibodies are found in the partially purified fractions. Activin expression was also marked in androgen-insensitive human prostate cancer PC-3 cells, but, scarce in androgen-sensitive LNCaP cells, suggesting that activin expression is correlated with hormone-unresponsive growth condition.3. FGF8 expression in human cancers and murine embryos: By use of our newly established neutralizing monoclonal antibody against murine and human FGF8, expression of FGF8 in various specimens was immunohistochemically examined. In human cancer specimens, FGF8 was frequently expressed in prostate cancers, but, not in prostate hyperplasias. In murine embryos, FGF8 was strongly expressed in differentiated neuronal cells. In addition, FGF8 had ability to promote neurite extension in cultured rat pheochromacytoma PC12 cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tanaka,A.et al: "High frequency of fibroblast growth factor(FGF)8 expression in clinical prostate cancers and breast tissues,Immunohistrochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF8" Cancer Research. 58. 205
Tanaka,A.等人:“临床前列腺癌和乳腺组织中成纤维细胞生长因子 (FGF)8 的高频率表达,通过新建立的针对 FGF8 的中和单克隆抗体进行免疫组织化学证明”癌症研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka, A. et al: "High frequency of fibroblast growth factor(FGF)8 expression in clinical prostate cancer and breast fissures immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF"Cancer Research. 58. 2053
Tanaka, A. 等人:“通过新建立的针对 FGF 的中和单克隆抗体,免疫组织化学证明了临床前列腺癌和乳腺裂隙中成纤维细胞生长因子 (FGF)8 的高频率表达”癌症研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mathematical Analyses on Sampling Theorems in Reproducing Kernel Hilbert Spaces
  • 批准号:
    24500001
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.41万
  • 财政年份:
    2012
  • 负责人:
    TANAKA Akira
  • 依托单位:
The evaluation method for the effect of the various unnatural video components on viewers using physiological indices.
  • 批准号:
    23500146
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.24万
  • 财政年份:
    2011
  • 负责人:
    TANAKA Akira
  • 依托单位:
Development of the diet therapy considering polymorphisms of metabolic syndrome related gene
  • 批准号:
    21500794
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2009
  • 负责人:
    TANAKA Akira
  • 依托单位:
Mathematical Properties of Sampling and Optimal Reproducing Kernels
  • 批准号:
    21700001
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.75万
  • 财政年份:
    2009
  • 负责人:
    TANAKA Akira
  • 依托单位:
国内基金
海外基金
Activin A诱导单核来源的朗格汉斯细胞在皮肤黑素瘤早期免疫抑制微环境形成中的作用及机制研究
  • 批准号:
    JCZRYB202500430
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
肾衰营养胶囊通过Activin A调节肾-骨 骼肌交互轴改善CKD-PEW的作用及机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    胡蓉
  • 依托单位:
SNORA14A/MT2A抗氧化轴失调介导Activin-A表达增加促进肝母细胞瘤进展的机制及临床价值研究
  • 批准号:
    82302615
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    朱佳蓓
  • 依托单位:
瘤内血小板通过Activin A/Smad3/PD-L1重编程肿瘤间质介导卵巢癌免疫逃逸的机制研究
  • 批准号:
    82303367
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    高越
  • 依托单位: